4.7 Article

Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test

Michiyo Suzuki et al.

Summary: The study investigated the implementation rate and pathogen detection rate of rapid diagnostic tests (RDTs) in COVID-19 patients in Japan. The results showed that influenza, Mycoplasma pneumoniae, and group A streptococcus were the most common pathogens detected. RDTs remain important for testing coinfection with other pathogens in COVID-19 patients.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2023)

Article Public, Environmental & Occupational Health

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Miwako Kobayashi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Immunology

Upsurge of Conjugate Vaccine Serotype 4 Invasive Pneumococcal Disease Clusters Among Adults Experiencing Homelessness in California, Colorado, and New Mexico

Bernard Beall et al.

Summary: Following the introduction of the 7-valent pneumococcal conjugate vaccine in the United States in 2000, cases of invasive pneumococcal disease due to serotype 4 significantly decreased in children and adults. However, starting in 2013, there was an increase in serotype 4 IPD cases among adults, with a higher incidence seen among persons experiencing homelessness. Genomic sequencing identified specific lineages driving the increase in serotype 4 IPD cases, primarily affecting individuals in Colorado, California, and New Mexico.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England

Zahin Amin-Chowdhury et al.

Summary: According to research data from England, there was a significant decrease in the incidence of invasive pneumococcal disease (IPD) after the COVID-19 lockdown. Coinfection of SARS-CoV-2 and IPD, while rare, was associated with high case-fatality rates, particularly among older adults. The study findings do not support broader extension of pneumococcal vaccination due to the rarity, age and serotype distribution of IPD/COVID-19 coinfections.

CLINICAL INFECTIOUS DISEASES (2021)

Article Virology

SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction

Stefanie Deinhardt-Emmer et al.

Summary: SARS-CoV-2 efficiently infects epithelial cells and damages both epithelial and endothelial cells, resulting in barrier dysfunction that allows viral spread. The study demonstrates that viral-induced host factors disrupt the epithelial-endothelial barrier function and promote viral dissemination.

JOURNAL OF VIROLOGY (2021)

Article Immunology

Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers

Suresh Pallikkuth et al.

Summary: This study found a correlation between influenza specific T cell immunity and immune responses to SARS-CoV-2 in healthcare workers who had past SARS-CoV-2 infection, suggesting a potential impact on immunity against COVID-19.

VACCINE (2021)

Review Multidisciplinary Sciences

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis

Jackson S. Musuuza et al.

Summary: Our study found that as many as 19% of patients with COVID-19 had co-infections and 24% had superinfections. The presence of either co-infection or superinfection was associated with poor outcomes, such as increased mortality.

PLOS ONE (2021)

Article Cell Biology

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Willianne Hoepel et al.

Summary: Patients diagnosed with COVID-19 tend to become critically ill around the activation of the adaptive immune response. Evidence shows that antibodies in serum may worsen the disease during seroconversion. High anti-spike IgG levels in critically ill patients with severe COVID-19 induce excessive inflammatory responses and may lead to pulmonary complications such as microvascular thrombosis.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Infectious Diseases

Co-infections in people with COVID-19: a systematic review and meta-analysis

Louise Lansbury et al.

JOURNAL OF INFECTION (2020)

Review Infectious Diseases

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Bradley J. Langford et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Article Immunology

Homelessness in Adults With Invasive Pneumococcal Disease in Calgary, Canada

Julie-Anne Lemay et al.

OPEN FORUM INFECTIOUS DISEASES (2019)

Review Infectious Diseases

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis

Eili Y. Klein et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2016)

Review Infectious Diseases

Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza

Mark L. Metersky et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)

Article Immunology

Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection

Christopher D. Paddock et al.

JOURNAL OF INFECTIOUS DISEASES (2012)